FMR CORP 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 1,215,002 2.771% |
-2,969,291 (-70.96%) |
Filing |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 4,184,293 9.545% |
459,718 (+12.34%) |
Filing |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 3,724,575 10.272% |
1,198,372 (+47.44%) |
Filing |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 2,526,203 6.967% |
-2,197,484 (-46.52%) |
Filing |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 4,723,687 13.155% |
946,049 (+25.04%) |
Filing |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Ikena Oncology, Inc. IKNA |
FMR CORP | 3,777,638 12.541% |
3,777,638 (New Position) |
Filing |